Genetically modified T-cells are targeting cancer cells thanks to a groundbreaking discovery that earned two scientists the 2018 Nobel Prize in Physiology or Medicine.
Making sense of the technology taking over our lives.
CNET - by Jessica Dolcourt
CNET - by Patrick Holland
CNET - by Abrar Al-Heeti
CNET - by Scott Stein, Vanessa Hand Orellana